Genprex, Inc. (GNPX)
NASDAQ: GNPX · Real-Time Price · USD
0.2917
+0.0332 (12.84%)
At close: Sep 12, 2025, 4:00 PM EDT
0.2793
-0.0124 (-4.25%)
After-hours: Sep 12, 2025, 7:59 PM EDT
Genprex Market Cap
Genprex has a market cap or net worth of $9.76 million as of September 12, 2025. Its market cap has increased by 286.22% in one year.
Market Cap
9.76M
Enterprise Value
8.42M
1-Year Change
286.22%
Ranking
Category
Stock Price
$0.29
Market Cap Chart
Since March 29, 2018, Genprex's market cap has decreased from $61.26M to $9.76M, a decrease of -84.07%. That is a compound annual growth rate of -21.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 9.76M | 34.74% |
| Dec 31, 2024 | 7.25M | -47.00% |
| Dec 29, 2023 | 13.67M | -80.37% |
| Dec 30, 2022 | 69.64M | 11.19% |
| Dec 31, 2021 | 62.63M | -64.95% |
| Dec 31, 2020 | 178.67M | 2,798.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.45B |
| Johnson & Johnson | 423.36B |
| AbbVie | 373.87B |
| UnitedHealth Group | 314.07B |
| AstraZeneca | 250.26B |
| Novo Nordisk | 244.96B |
| Novartis AG | 244.56B |
| Abbott Laboratories | 225.15B |